Home › Cardiovascular Disease › Vermont
Cardiovascular Disease clinical trials in Vermont
5 studies for Cardiovascular Disease are looking for participants at sites in Vermont.
Cities in Vermont
Product Surveillance Registry
- Burlington
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- The University of Vermont Medical Center, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, White River Junction
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357ELEVATE-HFpEF Clinical Study
- The University of Vermont Medical Center, Burlington
Recruiting
Ages 40 and older · All sexes · Updated Aug 3, 2026 · NCT06678841PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- University of Vermont, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.